TriSalus Life Sciences, Inc. (TLSI) Q3 2024 Earnings

TLSI·Reported November 14, 2024·Before market open

TriSalus Life Sciences, Inc. reported Q3 2024 revenue of $7.3M, missed analyst consensus of $7.4M by $28.7K. Diluted EPS came in at $-0.40, missed the $-0.36 consensus by $0.04.

Revenue

$7.3Mmissed by $28.7K

Consensus: $7.4M

Diluted EPS

$-0.40missed by $0.04

Consensus: $-0.36

SEC Filings

Earnings release8-K not filed yet

Quarterly report10-Q · 0001826667-24-000051

Financial Snapshot

Trailing eight quarters through Q3 2024

View all metrics

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

Q3 2024 Earnings FAQ

Common questions about TriSalus Life Sciences, Inc.'s Q3 2024 earnings report.

TriSalus Life Sciences, Inc. (TLSI) reported Q3 2024 earnings on November 14, 2024 before market open.

TriSalus Life Sciences, Inc. reported revenue of $7.3M and diluted EPS of $-0.40 for Q3 2024.

Revenue missed the consensus estimate of $7.4M by $28.7K. EPS missed the consensus estimate of $-0.36 by $0.04.

You can read the 10-Q periodic report (0001826667-24-000051) directly on SEC EDGAR. The filing index links above go to sec.gov.